Reading Roundup: Top Blog Posts from April 2017
It’s time for another edition of the Reading Roundup featuring the top blog posts from April 2017. Start off your week by kicking back and catching up on what the pharmaceutical industry was reading in April.
Serialization is a reality – now what? Learn from key industry experts with years of practical experience on working on global serialization implementation issues in a complex regulatory environment.
It is pharmaceutical industry managements’ responsibility to ensure that Data Integrity Governance systems are in place at their respective firms and that this is documented within the firm’s overall Quality Management System. Learn about the different components of the Data Integrity Governance system and the benefits of such a system in ensuring the reliability and accuracy of your data.
Get the principles and practical guidance you need to meet current expectations for the management of pharma GxP regulated records and data integrity.
In an effort to harmonize the clinical study drug supply labeling requirements, Chapter X of the Regulation provides rules for clinical labeling. Further, to fill perceived gaps in individual member state requirements, annex VI was added to the regulation with additional detail about clinical labeling requirements. Learn more about the clinical labeling of medicinal products used in European clinical trial regulations.
Learn what happened when representatives from pharmaceutical industry, including FDA, gathered for an open dialogue on how quality metrics is impacting the pharmaceutical industry.
Get these great articles delivered straight to your inbox by subscribing to iSpeak, the Official Information Resource of ISPE.